Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 101–200 of 1,000
Murray, C. W., Carr, M. G., Callaghan, O., Chessari, G., Congreve, M., Cowan, S., Coyle, J. E., Downham, R., Figueroa, E., Frederickson, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100059d · Cited by 184
Binding of Aryl Hydrocarbon Receptor (AhR) to AhR-interacting Protein
Bell, D. R., & Poland, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004236200 · Cited by 180
Li, Y., Zhang, T., Schwartz, S. J., & Sun, D. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2008.12.002 · Cited by 176
Rapid and Accurate Prediction and Scoring of Water Molecules in Protein Binding Sites
Ross, G. A., Morris, G. M., & Biggin, P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032036 · Cited by 177
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy
Porter, J. R., Fritz, C. C., & Depew, K. M. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.019 · Cited by 177
HSP90AB1: Helping the good and the bad
Haase, M., & Fitze, G. (2016) · Gene · doi:10.1016/j.gene.2015.08.063 · Cited by 179
Review: The HSP90 molecular chaperone—an enigmatic ATPase
Pearl, L. H. (2016) · Biopolymers · doi:10.1002/bip.22835 · Cited by 171
Self-citationBrough, P. A., Barril, X., Borgognoni, J., Chene, P., Davies, N. G. M., Davis, B., Drysdale, M. J., Dymock, B., Eccles, S. A., Garcia-Echeverria, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900357y · Cited by 173
A direct role for Hsp90 in pre-RISC formation in Drosophila
Miyoshi, T., Takeuchi, A., Siomi, H., & Siomi, M. C. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1875 · Cited by 165
Nandy, J. P., Prakesch, M., Khadem, S., Reddy, P. T., Sharma, U., & Arya, P. (2009) · Chemical Reviews · doi:10.1021/cr800188v · Cited by 171
Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues
Yu, X. M., Shen, G., Neckers, L., Blake, H., Holzbeierlein, J., Cronk, B., & Blagg, B. S. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0535864 · Cited by 172
Lundgren, K., Zhang, H., Brekken, J., Huser, N., Powell, R. E., Timple, N., Busch, D. J., Neely, L., Sensintaffar, J. L., Yang, Y.-C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0758 · Cited by 173
Geldanamycin and its anti-cancer activities
Fukuyo, Y., Hunt, C. R., & Horikoshi, N. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.07.010 · Cited by 167
Heat Shock Protein 90 as a Drug Target against Protozoan Infections
Pallavi, R., Roy, N., Nageshan, R. K., Talukdar, P., Pavithra, S. R., Reddy, R., Venketesh, S., Kumar, R., Gupta, A. K., Singh, R. K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155317 · Cited by 168
Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M. K., Sausville, E. A., Monks, A. P., & Woude, G. F. V. (2000) · PubMed · Cited by 168
Anticancer Agents That Counteract Tumor Glycolysis
Granchi, C., & Minutolo, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200176 · Cited by 166
ATPases as drug targets: learning from their structure
Chène, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd894 · Cited by 163
Cyclophilin 40 facilitates HSP90‐mediated RISC assembly in plants
Iki, T., Yoshikawa, M., Meshi, T., & Ishikawa, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.395 · Cited by 162
Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress
Arlander, S. J. H., Eapen, A. K., Vroman, B. T., McDonald, R. J., Toft, D. O., & Karnitz, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309054200 · Cited by 169
Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease
McNaught, K. S. P., & Olanow, C. W. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.012 · Cited by 165
Hsp90 Selectively Modulates Phenotype in Vertebrate Development
Yeyati, P. L., Bancewicz, R. M., Maule, J., & van Heyningen, V. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030043 · Cited by 157
Interaction of Radicicol with Members of the Heat Shock Protein 90 Family of Molecular Chaperones
Schulte, T. W. (1999) · Molecular Endocrinology · doi:10.1210/me.13.9.1435 · Cited by 161
Discovery and development of heat shock protein 90 inhibitors
Taldone, T., Sun, W., & Chiosis, G. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.087 · Cited by 162
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
Richter, K., Walter, S., & Buchner, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.064 · Cited by 159
Tumor Selectivity of Hsp90 Inhibitors: The Explanation Remains Elusive
Chiosis, G., & Neckers, L. (2006) · ACS Chemical Biology · doi:10.1021/cb600224w · Cited by 156
Donnelly, A. C., Mays, J. R., Burlison, J. A., Nelson, J. T., Vielhauer, G. A., Holzbeierlein, J. M., & Blagg, B. S. J. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801312r · Cited by 156
Hsp90 Regulates the Activity of Wild Type p53 under Physiological and Elevated Temperatures
Müller, L., Schaupp, A., Walerych, D., Wegele, H., & Büchner, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407687200 · Cited by 168
Eiseman, J. L., Lan, J. Q., Lagattuta, T. F., Hamburger, D. R., Joseph, E., Covey, J. M., & Egorin, M. J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0865-3 · Cited by 167
Turbyville, T. J., Wijeratne, E. M. K., Liu, M. X., Burns, A. M., Seliga, C. J., Luevano, L. A., David, C. L., Faeth, S. H., Whitesell, L., & Gunatilaka, A. A. L. (2006) · Journal of Natural Products · doi:10.1021/np058095b · Cited by 150
Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus
Galigniana, M. D., Harrell, J. M., O'Hagen, H. M., Ljungman, M., & Pratt, W. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402223200 · Cited by 150
Morra, G., Verkhivker, G., & Colombo, G. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000323 · Cited by 148
17AAG: low target binding affinity and potent cell activity--finding an explanation.
Chiosis, G., Huezo, H., Rosen, N. X., Mimnaugh, E. G., Whitesell, L. J., & Neckers, L. (2003) · PubMed · Cited by 166
Richardson, P. G. G., Mitsiades, C. S., Laubach, J. P., Lonial, S., Chanan-Khan, A. A., & Anderson, K. C. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08360.x · Cited by 157
Inhibition of Hsp90: a new strategy for inhibiting protein kinases
Sreedhar, A. S., Sőti, C., & Csermely, P. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.027 · Cited by 160
Concise Asymmetric Syntheses of Radicicol and Monocillin I
Garbaccio, R. M., Stachel, S. J., Baeschlin, D. K., & Danishefsky, S. J. (2001) · Journal of the American Chemical Society · doi:10.1021/ja011364+ · Cited by 147
A Rhizosphere Fungus Enhances Arabidopsis Thermotolerance through Production of an HSP90 Inhibitor
McLellan, C. A., Turbyville, T. J., Wijeratne, E. M. K., Kerschen, A., Vierling, E., Queitsch, C., Whitesell, L., & Gunatilaka, A. A. L. (2007) · Plant Physiology · doi:10.1104/pp.107.101808 · Cited by 146
Modulation of Morphogenesis in Candida albicans by Various Small Molecules
Shareck, J., & Belhumeur, P. (2011) · Eukaryotic Cell · doi:10.1128/ec.05030-11 · Cited by 142
Bras, G. L., Radanyi, C., Peyrat, J., Brion, J., Alami, M., Marsaud, V., Stella, B., & Renoir, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0707774 · Cited by 145
Sharp, S. Y., Prodromou, C., Boxall, K. J., Powers, M. V., Holmes, J. L., Box, G., Matthews, T. P., Cheung, K.-M. J., Kalusa, A., James, K. E., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0149 · Cited by 156
Self-citationStructure of the N-terminal Domain of GRP94
Soldano, K. L., Jivan, A., Nicchitta, C. V., & Gewirth, D. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308661200 · Cited by 138
Leach, M. D., Budge, S., Walker, L., Munro, C., Cowen, L. E., & Brown, A. J. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003069 · Cited by 131
Smith, J. R., Clarke, P. A., de Billy, E., & Workman, P. (2009) · Oncogene · doi:10.1038/onc.2008.380 · Cited by 134
Connor, J. H., McKenzie, M. O., Parks, G. D., & Lyles, D. S. (2007) · Virology · doi:10.1016/j.virol.2006.12.026 · Cited by 146
Holmes, J. L., Sharp, S. Y., Hobbs, S., & Workman, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3268 · Cited by 147
Nadanaciva, S., Bernal, A. J., Aggeler, R. J., Capaldi, R., & Will, Y. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.01.011 · Cited by 133
Lee, C., Park, H.-K., Jeong, H., Lim, J., Lee, A.-J., Cheon, K. Y., Kim, C.-S., Thomas, A. P., Bae, B., Kim, N. D., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511893n · Cited by 127
Bonvini, P., Gastaldi, T., Falini, B., & Rosolen, A. (2002) · PubMed · Cited by 143
Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors
Bhat, R., Tummalapalli, S. R., & Rotella, D. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500823a · Cited by 130
Wang, S., Xu, Y., Maine, E. A., Wijeratne, E. M. K., Espinosa‐Artiles, P., Gunatilaka, A. A. L., & Molnár, I. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.006 · Cited by 127
The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA‐dependent kinase PKR
Donzé, O., Abbas‐Terki, T., & Picard, D. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3771 · Cited by 134
Structural Studies on the Co-chaperone Hop and Its Complexes with Hsp90
Onuoha, S. C., Coulstock, E. T., Grossmann, J. G., & Jackson, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.013 · Cited by 142
Heat shock protein 90: its inhibition and function
Zuehlke, A. D., Moses, M. A., & Neckers, L. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0527 · Cited by 117
Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus
Whitesell, L., Robbins, N., Huang, D. S., McLellan, C. A., Shekhar-Guturja, T., LeBlanc, E. V., Nation, C. S., Hui, R., Hutchinson, A., Collins, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08248-w · Cited by 124
Neckers, L., Blagg, B., Haystead, T., Trepel, J. B., Whitesell, L., & Picard, D. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0877-2 · Cited by 120
An essential role for chloroplast heat shock protein 90 (Hsp90C) in protein import into chloroplasts
Inoue, H., Li, M., & Schnell, D. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219229110 · Cited by 133
Structural parameterization of the binding enthalpy of small ligands
Luque, I., & Freire, E. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10208 · Cited by 119
Weikl, T., Muschler, P., Richter, K., Veit, T., Reinstein, J., & Büchner, J. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4157 · Cited by 144
HSP90 regulates cell survival via inositol hexakisphosphate kinase-2
Chakraborty, A., Koldobskiy, M. A., Sixt, K. M., Juluri, K. R., Mustafa, A. K., Snowman, A. M., van Rossum, D. B., Patterson, R. L., & Snyder, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711168105 · Cited by 118
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs
Bayliss, R. W., Choi, J., Fennell, D. A., Fry, A. M., & Richards, M. W. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2117-6 · Cited by 127
Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment‐based Design Strategies
Huth, J. R., Park, C., Petros, A. M., Kunzer, A. R., Wendt, M. D., Wang, X., Lynch, C. L., Mack, J. C., Swift, K. M., Judge, R. A., et al. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00535.x · Cited by 116
Gooljarsingh, L. T., Fernandes, C., Yan, K., Zhang, H., Grooms, M., Johanson, K., Sinnamon, R. H., Kirkpatrick, R. B., Kerrigan, J., Lewis, T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602650103 · Cited by 116
Bagatell, R., Khan, O., Paine-Murrieta, G. D., Taylor, C. W., Akinaga, S., & Whitesell, L. J. (2001) · PubMed · Cited by 118
Clément, M., Leonhardt, N., Droillard, M., Reiter, I. M., Montillet, J., Genty, B., Laurière, C., Nussaume, L., & Noël, L. D. (2011) · PLANT PHYSIOLOGY · doi:10.1104/pp.111.174425 · Cited by 117
Batulan, Z., Taylor, D. M., Aarons, R. J., Minotti, S., Doroudchi, M. M., Nalbantoglu, J. N., & Durham, H. D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.017 · Cited by 130
Heat Shock Protein 70 (HSP70) Induction: Chaperonotherapy for Neuroprotection after Brain Injury
Kim, J. Y., Barua, S., Huang, M., Park, J., Yenari, M. A., & Lee, J. E. (2020) · Cells · doi:10.3390/cells9092020 · Cited by 123
Li, D., Li, C., Li, L., Chen, S., Wang, L., Li, Q., Wang, X., Lei, X., & Shen, Z. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.08.018 · Cited by 120
Kim, T. S., Jang, C., Kim, H. D., Lee, J. Y., Ahn, B.-Y., & Kim, J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0713 · Cited by 113
Hsp90: A New Player in DNA Repair?
Pennisi, R., Ascenzi, P., & Di Masi, A. (2015) · Biomolecules · doi:10.3390/biom5042589 · Cited by 112
“Of note, the Hsp90 inhibitors geldanamycin (a highly cytotoxic natural antibiotic isolated from Streptomyces hygroscopicus, which binds Hsp90 in the ATP-binding site) [4,65,69,126], its derivates 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) [26,70,127] and 17-dimethylaminoethylamino-17demethoxygeldanamycin (17-DM…”
BackgroundSharp, S. Y., Boxall, K. J., Rowlands, M., Prodromou, C., Roe, S. M., Maloney, A., Powers, M. V., Clarke, P. A., Box, G., Sanderson, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3473 · Cited by 117
Self-citationInsights into Radicicol Biosynthesis via Heterologous Synthesis of Intermediates and Analogs
卉, H. Z. 周., Qiao, K., Gao, Z., Vederas, J. C., & Tang, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183574 · Cited by 111
Halohydrin and Oxime Derivatives of Radicicol: Synthesis and Antitumor Activities
Agatsuma, T., Ogawa, H., Akasaka, K., Asai, A., Yamashita, Y., Mizukami, T., Akinaga, S., & Saitoh, Y. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00260-2 · Cited by 110
Natural Product Inspired N‐Terminal Hsp90 Inhibitors: From Bench to Bedside?
Khandelwal, A., Crowley, V. M., & Blagg, B. S. J. (2015) · Medicinal Research Reviews · doi:10.1002/med.21351 · Cited by 121
The ATPase Cycle of the Endoplasmic Chaperone Grp94
Frey, S., Leskovar, A., Reinstein, J., & Buchner, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704647200 · Cited by 109
Ochel (2001) · doi:10.1379/1466-1268(2001)006<0105:gtpoac>2.0.co;2
Rab‐αGDI activity is regulated by a Hsp90 chaperone complex
Sakisaka, T., Meerlo, T., Matteson, J., Plutner, H., & Balch, W. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf603 · Cited by 129
Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site
Matts, R. L., Dixit, A., Peterson, L. B., Sun, L., Voruganti, S., Kalyanaraman, P., Hartson, S. D., Verkhivker, G. M., & Blagg, B. S. J. (2011) · ACS Chemical Biology · doi:10.1021/cb200052x · Cited by 108
A history of the role of the hERG channel in cardiac risk assessment
Rampe, D., & Brown, A. M. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.03.005 · Cited by 107
Kumar, R., Musiyenko, A., & Barik, S. (2003) · Malaria Journal · doi:10.1186/1475-2875-2-30 · Cited by 113
Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis
Grandal, M. V., & Madshus, I. H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00298.x · Cited by 114
The Chemical Biology of Molecular Chaperones—Implications for Modulation of Proteostasis
Brandvold, K. R., & Morimoto, R. I. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.05.010 · Cited by 107
Workman, P. (2003) · PubMed · Cited by 118
Ligand-induced Conformational Shift in the N-terminal Domain of GRP94, an Hsp90 Chaperone
Immormino, R. M., Dollins, D. E., Shaffer, P. L., Soldano, K. L., Walker, M. A., & Gewirth, D. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405253200 · Cited by 104
Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents
Neckers, L., & Neckers, K. (2002) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.7.2.277 · Cited by 111
Chang, D.-J., An, H., Kim, K.-S., Kim, H. H., Jung, J., Lee, J. M., Kim, N., Han, Y. T., Yun, H., Lee, S.-J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301488q · Cited by 102
Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment
Patel, H., Modi, S., Chiosis, G., & Taldone, T. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.563296 · Cited by 107
Development of a Fluorescence Polarization Assay for the Molecular Chaperone Hsp90
Kim, J., Felts, S. J., Llauger, L., He, H., Huezo, H., Rosen, N. X., & Chiosis, G. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265995 · Cited by 109
Pattern Recognition in Retrosynthetic Analysis: Snapshots in Total Synthesis
Wilson, R. M., & Danishefsky, S. J. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo070871s · Cited by 101
The ATPase Cycle of the Mitochondrial Hsp90 Analog Trap1
Leskovar, A., Wegele, H., Werbeck, N. D., Buchner, J., & Reinstein, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709516200 · Cited by 97
Shelton, S. N., Shawgo, M. E., Matthews, S. B., Lu, Y., Donnelly, A. C., Szabla, K., Tanol, M., Vielhauer, G. A., Rajewski, R. A., Matts, R. L., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058545 · Cited by 99
Cloutier, P., & Coulombe, B. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.02.010 · Cited by 108
Dahiya, V., Agam, G., Lawatscheck, J., Rutz, D. A., Lamb, D. C., & Buchner, J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.026 · Cited by 89
Enomoto, Y., Bharti, A. K., Khaleque, A. A., Song, B., Liu, C., Apostolopoulos, V., Xing, P., Calderwood, S. K., & Gong, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5946 · Cited by 94
Shen, W., Mao, H., Huang, Q., & Dong, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.067 · Cited by 94
Kampmueller, K. M., & Miller, D. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6827-6837.2005 · Cited by 88
Li, Y., Zhang, T., Jiang, Y., Lee, H.-F., Schwartz, S. J., & Sun, D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900037p · Cited by 99
Ambade, A., Catalano, D., Lim, A., & Mandrekar, P. (2011) · Hepatology · doi:10.1002/hep.24802 · Cited by 99
Hsp90 as a Target for Drug Development
Chaudhury, S., Welch, T. R., & Blagg, B. S. J. (2006) · ChemMedChem · doi:10.1002/cmdc.200600112 · Cited by 102
Wang, L., Sullivan, W., Toft, D. O., & Weinshilboum, R. M. (2003) · Pharmacogenetics · doi:10.1097/00008571-200309000-00004 · Cited by 99
Meli, M., Pennati, M., Curto, M., Daidone, M. G., Plescia, J., Toba, S., Altieri, D. C., Zaffaroni, N., & Colombo, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060836y · Cited by 93
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.